SynPlexity

SynPlexity is an artificial intelligence company in EUGENE, United States, founded in 2024. It has 1 recorded funding round, most recently a Pre-Seed in 2024 (est.).

Transforming synthetic biology with precise, cost-effective gene libraries.

Headquarters
EUGENE, Oregon
Employees
1–10
Founded
2024
Business Model
B2B
Last Round
Pre-SeedJan 2024
Rounds
1

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

SynPlexity enables researchers to scale biology with multiplexed DNA libraries — delivering more variants, faster discovery, and lower cost using proprietary DropSynth microreactor technology. The platform serves protein engineering, drug discovery, and functional genomics workflows, providing gene libraries up to 25,000+ fragments with in-house NGS quality control.

Summary

It lists 1–10 employees. Its most recent funding was a Pre-Seed round in 2024 (est.). Investors include Portland Seed Fund and SOSV.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Pre-seedPre-Seed2024 (est.)

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SynPlexity on Indexed.vc
<a href="https://indexed.vc/companies/synplexity"><img src="https://indexed.vc/api/badge/company/synplexity" alt="SynPlexity on Indexed.vc" width="260" height="76" /></a>